American Academy of Dermatology (AAD) Annual Meeting 2026 (Videos)

Comprehensive Updates in Medical Dermatology, Dermatologic Surgery, Pediatric Dermatology, Cutaneous Oncology, Biologic Therapies, Precision Medicine, Artificial Intelligence & Cosmetic Dermatology

Stay at the forefront of modern dermatology with the American Academy of Dermatology (AAD) Annual Meeting 2026, the world’s premier educational conference dedicated to comprehensive dermatologic care. Bringing together internationally recognized dermatologists, researchers, surgeons, educators, and innovators, this prestigious annual meeting showcases the latest scientific discoveries, groundbreaking clinical trials, evidence-based treatment strategies, and emerging technologies that are redefining the future of dermatology.

The 2026 AAD Annual Meeting arrives during a transformative era marked by phase III clinical trial breakthroughs, next-generation biologic therapies, oral precision medicines, and first-in-class therapeutic innovations. The program delivers comprehensive updates across medical dermatology, dermatologic surgery, pediatric dermatology, dermatopathology, cosmetic dermatology, cutaneous oncology, and digital health, with special emphasis on historically underserved inflammatory and autoimmune skin diseases.

Through expert-led lectures, clinical case discussions, procedural demonstrations, guideline reviews, and evidence-based educational sessions, participants gain practical knowledge that can immediately improve diagnostic accuracy, treatment selection, procedural outcomes, and long-term patient care.

Product Details

• Course: American Academy of Dermatology (AAD) Annual Meeting 2026
• Provider: American Academy of Dermatology (AAD)
• Format: Videos
• Language: English
• Educational Level: Advanced
• Learning Format: Scientific Lectures, Clinical Updates, Expert Panels, Procedural Demonstrations, Case-Based Discussions

Course Overview

Dermatology continues to experience extraordinary advances driven by precision medicine, molecular immunology, biologic therapeutics, artificial intelligence, digital imaging, and minimally invasive procedural innovations. New treatments are rapidly transforming the management of inflammatory skin diseases, pigmentary disorders, skin cancer, autoimmune conditions, and aesthetic dermatology.

The AAD Annual Meeting 2026 provides a comprehensive review of these developments through internationally respected faculty who present the latest research, clinical guidelines, pivotal phase III trial results, and real-world treatment strategies. Participants gain practical insights into emerging therapies for atopic dermatitis, plaque psoriasis, hidradenitis suppurativa, vitiligo, skin cancer, hair disorders, nail disease, mucosal disorders, and pediatric dermatology while also exploring innovations in AI-assisted diagnosis, teledermatology, and practice management.

This multidisciplinary educational program equips clinicians with the knowledge and procedural skills needed to provide state-of-the-art dermatologic care across every stage of clinical practice.

What You’ll Learn

After completing this course, participants will be able to:

• Apply the latest evidence-based advances in medical dermatology and dermatologic surgery.
• Integrate new biologic agents and oral precision therapies into individualized treatment plans.
• Diagnose and manage inflammatory, autoimmune, pigmentary, hair, nail, and mucosal disorders using current clinical guidelines.
• Incorporate emerging technologies including artificial intelligence and teledermatology into clinical workflows.
• Improve procedural techniques for dermatologic surgery and cosmetic dermatology.
• Evaluate late-breaking clinical trial data and first-in-class therapeutic innovations.
• Strengthen dermatology practice management and quality improvement strategies.
• Deliver multidisciplinary, patient-centered dermatologic care.

Comprehensive Topics Covered

Medical Dermatology

Master evidence-based management of common and complex skin diseases.

Topics include:

• Medical dermatology
• Inflammatory dermatoses
• Autoimmune skin diseases
• Chronic skin disorders
• Clinical diagnosis
• Evidence-based therapy
• Comprehensive patient management

Faculty review modern treatment algorithms supported by the latest clinical evidence.

Atopic Dermatitis

Review rapidly evolving treatment options for eczema.

Topics include:

• Atopic dermatitis
• Eczema
• JAK inhibitors
• Biologic therapies
• Precision medicine
• Long-term disease control
• Treatment optimization

Plaque Psoriasis

Explore current standards and emerging therapies.

Topics include:

• Plaque psoriasis
• Psoriatic disease
• IL-17 inhibitors
• IL-23 inhibitors
• Oral therapies
• Systemic treatment
• Personalized care

Hidradenitis Suppurativa (HS)

Strengthen management of complex inflammatory disease.

Topics include:

• Hidradenitis suppurativa
• Chronic inflammation
• Biologic treatment
• Surgical management
• Combination therapy
• Disease severity
• Long-term management

Vitiligo & Pigmentary Disorders

Update diagnostic and therapeutic strategies.

Topics include:

• Vitiligo
• Pigment disorders
• Repigmentation therapies
• Topical treatments
• Systemic therapy
• Phototherapy
• Emerging biologics

Cutaneous Oncology

Improve diagnosis and treatment of skin cancer.

Topics include:

• Melanoma
• Basal cell carcinoma
• Cutaneous squamous cell carcinoma
• Merkel cell carcinoma
• Skin cancer screening
• Surgical oncology
• Immunotherapy

Dermatologic Surgery

Enhance procedural expertise.

Topics include:

• Dermatologic surgery
• Skin reconstruction
• Surgical techniques
• Mohs surgery principles
• Excisional surgery
• Cosmetic procedures
• Postoperative management

Pediatric Dermatology

Strengthen care of dermatologic disorders in children.

Topics include:

• Pediatric dermatology
• Infant skin disorders
• Genetic skin disease
• Pediatric inflammatory disease
• Birthmarks
• Pediatric eczema
• Congenital disorders

Hair, Nail & Mucosal Disorders

Expand expertise beyond common skin disease.

Topics include:

• Alopecia
• Hair disorders
• Nail disorders
• Oral mucosal disease
• Scalp disorders
• Diagnostic evaluation
• Medical management

Artificial Intelligence & Teledermatology

Explore the digital future of dermatology.

Topics include:

• Artificial intelligence
• Teledermatology
• Digital imaging
• Clinical decision support
• Machine learning
• Diagnostic technology
• Virtual dermatology care

Faculty discuss how digital innovation is improving access, efficiency, and diagnostic accuracy.

Cosmetic Dermatology

Review modern aesthetic treatment techniques.

Topics include:

• Cosmetic dermatology
• Injectable therapies
• Laser treatments
• Skin rejuvenation
• Energy-based devices
• Facial aesthetics
• Combination procedures

Dermatopathology & Diagnostic Advances

Improve clinicopathologic correlation.

Topics include:

• Dermatopathology
• Histopathology
• Skin biopsy interpretation
• Molecular diagnostics
• Precision diagnosis
• Biomarkers
• Clinical-pathologic correlation

Practice Management & Professional Development

Strengthen successful dermatology practice.

Topics include:

• Practice management
• Quality improvement
• Workflow optimization
• Patient communication
• Risk management
• Clinical efficiency
• Professional development

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Apply current knowledge and procedural skills across medical dermatology, dermatologic surgery, pediatric dermatology, and dermatopathology.
• Integrate recent advances in diagnosing and treating diseases affecting the skin, hair, nails, and mucous membranes.
• Evaluate evidence-based diagnostic approaches alongside newly approved biologics, oral precision therapies, and emerging dermatologic treatments.
• Improve dermatology practice management, workflow efficiency, and quality of patient care.
• Incorporate newly acquired procedural techniques and evidence-based therapies into everyday dermatology practice.

Educational Highlights

• Medical Dermatology
• Dermatologic Surgery
• Pediatric Dermatology
• Cosmetic Dermatology
• Dermatopathology
• Cutaneous Oncology
• Atopic Dermatitis
• Plaque Psoriasis
• Hidradenitis Suppurativa (HS)
• Vitiligo
• Biologic Therapies
• Precision Medicine
• Artificial Intelligence
• Teledermatology
• Laser Dermatology
• Skin Cancer
• Hair Disorders
• Nail Disorders
• Evidence-Based Dermatology
• Continuing Medical Education (CME)

Why This Course Stands Out

The American Academy of Dermatology Annual Meeting 2026 represents the most comprehensive educational event in dermatology, delivering a complete review of the latest scientific discoveries, breakthrough therapies, procedural innovations, and evolving clinical guidelines. With extensive coverage of late-breaking phase III trials, first-in-class biologic agents, precision medicine, artificial intelligence, and digital dermatology, the meeting equips clinicians with practical knowledge that immediately translates into improved patient care. Its unparalleled breadth across medical, surgical, pediatric, cosmetic, and oncologic dermatology makes it an essential educational resource for every dermatology professional.

Target Audience

This educational activity is ideal for:

• Dermatologists
• Dermatologic Surgeons
• Pediatric Dermatologists
• Cosmetic Dermatologists
• Dermatopathologists
• Cutaneous Oncologists
• Mohs Surgeons
• Plastic Surgeons with Dermatologic Interest
• Allergy & Immunology Physicians
• Rheumatologists treating immune-mediated skin diseases
• Dermatology Residents
• Dermatology Fellows
• Advanced Practice Providers in Dermatology
• Healthcare Professionals involved in comprehensive dermatologic care

Why Choose This Course?

Whether you specialize in medical dermatology, dermatologic surgery, pediatric dermatology, cosmetic procedures, dermatopathology, or skin cancer management, the American Academy of Dermatology Annual Meeting 2026 provides one of the most comprehensive educational experiences available. Through internationally recognized faculty, evidence-based lectures, late-breaking clinical trial updates, procedural demonstrations, and multidisciplinary discussions, participants gain the expertise needed to integrate innovative therapies, refine diagnostic skills, enhance procedural outcomes, and deliver exceptional dermatologic care across every patient population.

Topics

The comprehensive scientific agenda spans multiple core specialties within dermatology. Detailed topics covered during the meeting include:

Medical Dermatology & Pipeline Therapeutics

• Next-Generation Oral Therapies: Evaluating high-performance oral agents closing the efficacy gap with biologics, including Icotrokinra (an oral IL-23 receptor antagonist) for plaque psoriasis without mandatory TB testing requirements.

• Novel Biologics in Atopic Dermatitis: 24-week efficacy and safety results from the COAST 1 and COAST 2 Phase 3 trials investigating Amlitelimab (a non-depleting anti-OX40 ligand antibody) as monotherapy and alongside topical treatments.

• Advancements in Non-Segmental Vitiligo: Efficacy and safety profiles of Upadacitinib in adolescents and adults based on the Viti-Up Phase 3 studies.

• Hidradenitis Suppurativa (HS) Breakthroughs: Assessment of durable 54-week efficacy data for the oral JAK1 inhibitor Povorcitinib, highlighting its favorable safety profile and mechanistically targeted reduction of heterogeneous cytokine architecture in HS.

Dermatologic Surgery & Cutaneous Oncology

• Melanoma Care Disparities: Analyzing survival outcomes and racial/gender disparities across the melanoma care continuum, including evidence showing lower rates of home or hospice end-of-life care among minority patients.

• Surgical Technique Updates: Procedural integration and guidelines for managing challenging cutaneous malignancies and complex dermatologic anomalies.

Inflammatory & Autoimmune Diseases

• Systemic Inflammation & Cardiovascular Risk: Transcriptomic evidence linking psoriasis and atopic dermatitis to shared atherosclerotic risk pathways.

• The “Diaper to Diaper” Hypothesis: Tracing systemic inflammation from growth stunting in pediatric atopic dermatitis to cardiovascular disease manifestations in adult patients.

• TYK2 Inhibitors & Safety Profiles: Phase 2b and Phase 3 efficacy of allosteric TYK2 inhibitors (e.g., envudeucitinib, zasocitinib) that preserve clinical efficacy while minimizing JAK-associated safety concerns.

Pediatric Dermatology

• Biologic Interventions in Adolescents: Assessing robust Phase 3 responses (PASI 90 and PASI 100) to targeted treatments in adolescent cohorts weighing ≥40 kg.

• Adolescent vs. Adult Pathophysiology: Investigating understudied pathophysiologic distinctions, such as those observed in teenage versus adult female acne.

Aesthetic & Cosmetic Dermatology

• Cosmetic Injections: Practical approaches to product selection, relevant anatomy review, injection methods for botulinum toxin and dermal fillers, and strategies to minimize adverse events.

• Scalp & Hair Expertise: Understanding physiological and structural specificities (e.g., straight vs. curly hair biology) to optimize outcomes for hair loss, dandruff, and cosmetic compliance.

• Compliance-Driven Galenics: Bridging the gap between clinical potency and sensory/cosmetic appeal to improve treatment adherence across diverse patient profiles.

Technology, Practice Management & Diversity

• Digital Dermatologic Innovation: Evaluating the pros, cons, and clinical integration of Artificial Intelligence (AI) and Teledermatology to manage workload and expand patient access.

• Clinical Trial Diversity: Strategies for improving remote dermatology care, ensuring accurate diagnosis in skin of color, and boosting diverse representation in late-stage clinical research.

• Antibiotic Stewardship: Reframing antibiotics in acne management as anti-inflammatory rather than antimicrobial agents, focusing on narrow-spectrum agents (like sarecycline) to preserve gut microbiome integrity.